Embolic protection and platelet inhibition during renal artery stenting

Circulation

Volumn 117, Issue 21, 2008, Pages 2752-2760

  Cooper, Christopher J ^a,k   Haller, Steven T ^a   Colyer, William ^a   Steffes, Michael ^b   Burket, Mark W ^a   Thomas, William J ^c   Safian, Robert ^d   Reddy, Bhagat ^e   Brewster, Pamela ^a   Ankenbrandt, Mary Ann ^a   Virmani, Renu ^f   Dippel, Eric ^g   Rocha Singh, Krishna ^h   Murphy, Timothy P ⁱ   Kennedy, David J ^a   Shapiro, Joseph I ^a   D'Agostino, Ralph D ^j   Pencina, Michael J ^j   Khuder, Sadik ^a  

^a UNIVERSITY OF TOLEDO   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Pima Research   (United States)

^d WILLIAM BEAUMONT HOSPITAL   (United States)

^e Fuqua Heart Center   (United States)

^f CVPATH INSTITUTE   (United States)

^g Midwest Cardiovascular Research   (United States)

^h Prairie Cardiovascular   (United States)

ⁱ BROWN UNIVERSITY   (United States)

^j BOSTON UNIVERSITY   (United States)

^k MEDICAL COLLEGE OF OHIO   (United States)

more..

Author keywords

Kidney; Peripheral vascular disease; Platelets; Stenosis; Stents

Indexed keywords

ABCIXIMAB; ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BICARBONATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; THIENOPYRIDINE DERIVATIVE; WARFARIN;

AGED; ARTICLE; BIOFILTER; BLEEDING; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DIET; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY ARTERY; KIDNEY ARTERY EMBOLISM; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION TEST; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; STENT; THROMBOCYTE; THROMBUS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; ANTIBODIES, MONOCLONAL; BLOOD PRESSURE; COMBINED MODALITY THERAPY; EMBOLISM; FEMALE; GLOMERULAR FILTRATION RATE; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INTRAOPERATIVE COMPLICATIONS; KIDNEY DISEASES; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; STENTS; TREATMENT OUTCOME;

EID: 44449158362     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.730259     Document Type: Article

References (31)

1. Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension: production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59:347-379.
2. Pickering TG. Diagnosis and evaluation of renovascular hypertension. Circulation. 1991;83(suppl):I-147-I-154.
3. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-441.
4. Babooloal K, Evans C, Moore R. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis. 1998;31:971-977.
5. Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH. Prevalence of renovascular disease in the elderly: a population based study. J Vasc Surg. 2002;36:443-451.
6. Iannone LA, Underwood PL, Nath A, Tannenbaum MA, Ghali MG, Clevenger LD. Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensives and renal insufficient patients with renal artery stenosis. Cathet Cardiovasc Diagn. 1996;37:243-250.
7. Henry M, Klonaris C, Henry I, Tzetanov K, Le Borgne E, Foliguet B, Hugel M. Protected renal stenting with the Percusurge Guardwire device: a pilot study. J Endovasc Ther. 2001;8:227-237.
8. Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg. 2003;38:962-968.
9. Edwards MS, Craven BL, Stafford J, Craven TE, Sauve KJ, Ayerdi J, Geary RL, Hansen KJ. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg. 2006;44:128-135.
10. EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularization. N Engl J Med. 1997;336:1689-1696.
11. Gianello P, Janssen T, Chatzopoulos C, Kartheuser A, Lambotte L, Squifflet JP, Alexandre GP. Beneficial effect of piracetam on renal blood flow in ischemically injured kidneys in the rat. Transplant Proc. 1988;20:914-916.
12. Masumura H, Kunitada S, Irie K, Ashida S, Abe Y. A thromboxane A2 synthase inhibitor, DP-1904, prevents rat renal injury. Eur J Pharmacol. 1991;193:321-327.
13. US Department of Health and Human Services. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Available at: www.nhlbi.nih.gov/guidelines/hypertension/ jnc7full.pdf. Accessed May 7, 2007.
14. Uehata A, Matsuguchi T, Bittl JA, Orav J, Meredith IT, Anderson TJ, Selwyn AP, Ganz P, Yeung AC. Accuracy of electronic digital calipers compared with quantitative angiography in measuring coronary arterial diameter. Circulation. 1993;88:1724-1729.
15. Gardiner GA, Bonn J, Sullivan KL. Quantification of elastic recoil after balloon angioplasty in the iliac arteries. J Vasc Interv Radiol. 2001;12:1389-1393.
16. Burches B, Krzysztof K, Waldemar W, McBane RD 2nd. Immunohistochemistry of thrombi following iliac venous stenting: a novel model of venous thrombosis. Thromb Haemost. 2006;96:618-622.
17. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473-2483.
18. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N latex cystatin C assay on the Dade Behring Nephelometer system. Scand J Clin Lab Invest. 1999;59:1-8.
19. Sokal RR, Rohlf FJ. Biometry. 2nd ed. San Francisco, Calif: W.H. Freeman and Co; 1981:454-539.
20. Peter J, Wasserman W, Kutner MH. Applied Linear Statistical Models. 3rd ed. Boston, Mass: Richard D. Irwin, Inc; 1990:861-906.
21. Van der Ven PJ, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Buskens E, Koomans HA, Mali WP. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353:282-286.
22. Rocha-Singh K, Jaff MR, Rosenfield K. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty the ASPIRE-2 study. J Am Coll Cardiol. 2005;46:776-783.
23. Sapoval M, Zahringer M, Pattynama P, Rabbia C, Vignali C, Maleux G, Boyer L, Szczerbo-Trojanowaska M, Jaschke W, Hafsahl G, Downes M, Paul Beregi J, Beeger N, Talen A. Low-profile stent system for treatment of atherosclerotic renal artery stenosis: the GREAT trial. J Vasc Interv Radiol. 2005;16:1195-1202.
24. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B, for the American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463-e654.
25. Dorros G, Jaff M, Mathiak L, Lynne RN, Dorros II, Lowe A, Murphy K, He T. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642-647.
26. Kennedy DJ, Colyer WR, Brewster PS, Ankenbrandt M, Burket M, Nemeth AS, Khuder SA, Thomas WJ, Shapiro JI, Cooper CJ. Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. Am J Kidney Dis. 2003;42:926-935.
27. Watson PS, Hadjipetrou P, Cox SV, Piemonte TC, Eisenhauer AC. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000;102:1671-1677.
28. Harden PN, MacLeod MJ, Rodger RSC, Baxter GM, Connell JMC, Dominiczak AF, Junor BJR, Briggs JD, Moss JG. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet. 1997;349:1133-1136.
29. Jonas M, Stone GW, Mehran R, Hermiller J, Feldman R, Herrmann HC, Cox DA, Kuntz RE, Popma JJ, Rogers C. Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection. Eur Heart J. 2006;27:920-928.
30. van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, Dees A, Woittiez AJ, Bartelink AK, Veld M, Schalekamp MA. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. N Engl J Med. 2000;342:1007-1014.
31. Cooper CJ, Murphy TP, Matsumoto A, Steffes M, Cohen DJ, Jaff M, Kuntz R, Jamerson K, Reid D, Rosenfield K, Rundback J, D'Agostino R, Henrich W, Dworkin L. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J. 2006;152:59-66.